UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d) OF THE

~~OF THE~~ SECURITIES EXCHANGE ACT OF 1934

Date of Report (Date of earliest event reported): October 14 31, 2022

SANDBRIDGE X2 CORP

(Exact name of registrant as specified in its charter)

Delaware	001-40183	~~001~~86-~~40183~~1544667		~~86-1544667~~
(State or other jurisdiction of incorporation)	(Commission File Number)	(~~Commission~~IRS ~~File~~Employer ~~Number~~Identification No.)		~~(IRS EmployerIdentification No.)~~

725 5th Ave, 23rd Floor New York, NY		10022
(Address of principal executive offices)		(Zip Code)

Registrant’s telephone number, including area code: (212) 292-7870

Not Applicable

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐	Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐☒ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class	Trading Symbol(s)	Name of each exchange on which registered
Units, each consisting of one share of Class A common stock, $0.0001 par value, and one-third of one redeemable warrant	SBII.U	New York Stock Exchange LLC
Shares of Class A common stock included as part of the units	SBII	New York Stock Exchange LLC
Redeemable warrants, included as part of the units, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50	SBII WS	New York Stock Exchange LLC
Redeemable warrants included as part of the Units, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50		NONE

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 38.01 ~~Notice~~Other ~~of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing~~Events.

On October 14 31, 2022, ~~the~~Sandbridge ~~New~~X2 ~~York~~Corp ~~Stock Exchange~~ (the “~~NYSE~~Company”) ~~notified~~filed ~~Sandbridge~~a X2definitive ~~Corp~~proxy statement relating to a special meeting of stockholders to approve (i) an amendment to the “Company’s Amended and Restated Certificate of Incorporation (the “Charter Amendment Proposal”) ~~that~~and ~~the~~(ii) ~~NYSE~~an ~~determined~~amendment to ~~commence~~the ~~proceedings~~Investment toManagement ~~delist~~Trust Agreement, dated March 9, 2021, by and between the Company’s ~~warrants~~and Continental Stock Transfer & Trust Company, ~~each~~as ~~exercisable~~trustee ~~for~~(the ~~one~~“Trust ~~share~~Amendment ofProposal” and together with the Charter Amendment Proposal, the “Proposals”), which would, if implemented, allow the Company’s to redeem all of its outstanding Class A common stock, par ~~from~~value ~~the~~$0.0001 ~~NYSE~~per ~~and~~share ~~that~~(the ~~trading~~“Public Shares”) in advance of the Company’s ~~warrants~~original ~~would~~deadline beof ~~suspended~~March ~~immediately~~12, ~~due~~2023 toby ~~“abnormally~~changing ~~low”~~the ~~trading~~date ~~price~~by ~~levels~~which ~~pursuant~~the toCompany ~~Section 802.01D~~must ofconsummate ~~the~~a ~~NYSE~~merger, ~~Listed~~capital ~~Company~~stock ~~Manual.~~exchange, ~~The~~asset ~~NYSE~~acquisition, ~~issued~~stock apurchase, reorganization ~~press~~or ~~release~~similar ~~stating~~business ~~the~~combination ~~foregoing~~from onMarch ~~October 17~~12, 2023 to December 15, 2022. ~~The~~or ~~Company~~such ~~does~~earlier ~~not~~date ~~intend~~as tois ~~appeal~~determined by the ~~NYSE~~Company’s ~~determination~~board of directors in its sole discretion (the “Amended Termination Date”).

AIn ~~copy~~connection with the approval of the ~~press~~Charter ~~release~~Amendment isProposal, ~~furnished~~the ~~hereto~~holders asof ~~Exhibit~~Public 99Shares may elect to redeem all or a portion of their Public Shares in exchange for their pro rata portion of the funds held in the trust account (the “Voluntary Redemption”).1 The Company will redeem all Public Shares not elected to participate in the Voluntary Redemption substantially concurrently with the Voluntary Redemption (all such redemptions together, the “Post-Amendment Share Redemption”). The Company expects to complete the Post-Amendment Share Redemption on or around December 2, 2022 if stockholders approve the Proposals. Additionally, the last day of trading of the Public Shares will be November 29, 2022, if stockholders approve the Proposals. For questions regarding redemptions, please contact Sandbridge’s transfer agent:

Mark Zimkind

Continental Stock Transfer & Trust Company

One State Street Plaza, 30^th Floor

New York, New York 10004

E-mail: mzimkind@continentalstock.com

The estimated redemption price as of November 15, 2022, is estimated to be approximately $10.09 per share, which is expected to be similar to the redemption price on the anticipated redemption date.

The special meeting will be held on Tuesday, November 29, 2022, at 10:00 a.m. Eastern Time, and the record date for the meeting is the close of business (New York time) on October 31, 2022.

A copy of the press release is filed herewith as Exhibit 99.1 in compliance with Rule 14a-12 under the Securities and Exchange Act of 1934, as amended, and is incorporated herein by reference.

The information contained in this Item 8.01 and the accompanying Exhibit 99.1 are furnished and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that section or Sections 11 and 12(a)(2) of the Securities Act of 1933, as amended, nor shall they be deemed incorporated by reference in any filing with the Securities and Exchange Commission (the “SEC”) made by the Company, whether made before or after the date hereof, regardless of any general incorporation language in such filing.

Forward-Looking Statements

Certain statements included in this Current Report on Form 8-K are “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, that are not historical facts, including with respect to the Company’s anticipated redemption, liquidation and dissolution, and involve risks and uncertainties that could cause actual results to differ materially from those expected and projected. Words such as “expect,” “believe,” “anticipate,” “intend,” “estimate,” “seek,” “future,” “project,” “anticipate” and variations and similar words and expressions are intended to identify such forward-looking statements. Such forward-looking statements relate to future events or future performance, but reflect management’s current beliefs, based on information currently available. A number of factors could cause actual events, performance or results to differ materially from the events, performance and results discussed in the forward-looking statements. For information identifying important factors and risks that could cause actual results to differ materially from those anticipated in the forward-looking statements, please refer to the Company’s Annual Report on Form 10-K, Quarterly Reports on Form 10-Q and other documents filed with the SEC. Copies of such filings are available on the SEC’s website, www.sec.gov.

Forward-looking statements speak only as of the date they are made, and the Company assumes no obligation and does not intend to update or revise these forward-looking statements, whether as a result of new information, future events, or otherwise, except as required by law. Nothing in this Current Report on Form 8-K should be regarded as a representation by any person that the forward-looking statements set forth herein will be achieved or that any of the contemplated results of such forward-looking statements will be achieved. The inclusion of any statement in this Current Report on Form 8-K does not constitute an admission by the Company or any other person that the events or circumstances described in such statements are material.

Additional Information

Nothing in the foregoing communication shall constitute a solicitation to buy or an offer to sell any of the Company’s securities. The Company’s stockholders and other investors are urged to read the definitive proxy statement (which has been filed with the SEC) because it contains important information relating to the proposed transaction. Copies of the Company’s SEC filings are available free of charge at the SEC’s website (http://www.sec.gov). Copies of the filings together with the materials incorporated by reference therein will also be available, without charge, by directing a request to: Sandbridge X2 Corp, 725 5th Ave, 23rd Floor, New York, NY 10022.

Participants in a Solicitation

The directors and executive officers of the Company and other persons may be deemed to be participants in the solicitation of proxies in respect of the stockholder proposals relating to the proposed early redemption transactions. Information regarding the directors and executive officers of the Company and their direct and indirect interests in the Company, by security holdings or otherwise, is available in the Company’s definitive proxy statement filed in connection with the Special Meeting of Stockholders to be held on Tuesday, November 29, 2022, which was filed with the SEC on October 31, 2022. Free copies of these documents may be obtained as described in the preceding paragraph.

Item 9.01.

Financial Statements and Exhibits.

(d) Exhibits

ExhibitNo.		Description
Exhibit No.		Description
99.1		Press Release, dated ~~October~~November 1716, 2022
104		Cover Page Interactive Data File (formatted as Inline XBRL)

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

~~SANDBRIDGE X2 CORP~~	SANDBRIDGE X2 CORP
~~By:~~	By:	/s/ Richard Henry
~~Name:~~	Name:	Richard Henry
~~Title:~~	Title:	Chief Financial Officer
Date: November 16, 2022

Date: October 18, 2022

Filing Compare · Sandbridge X2 Corp